Pharmaco - Press Releases

Date	Title	Company
17-Jan-2023	Leading global pharma firms exit UK drug pricing agreement	ABPI
17-Jan-2023	Approval of GMP Registration by MHRA	Celadon Pharmaceuticals Plc
17-Jan-2023	Poolbeg announces strategic expansion of POLB 001 into oncology	Poolbeg Pharma Plc
17-Jan-2023	Eckert & Ziegler Exceeds Forecast for the 2022 Financial Year According to Preliminary Figures	Eckert & Ziegler Strahlen- und Medizintechnik AG
17-Jan-2023	ImmunOs Therapeutics Receives Regulatory Approval for First-In-Human Trial of IOS-1002	ImmunOs Therapeutics
17-Jan-2023	Pan Cancer T Appoints Dr. Rachel Abbott as Chief Scientific Officer	Pan Cancer T
17-Jan-2023	Kinarus Therapeutics Reports Preclinical Data in Lung Fibrosis and Discloses Clinical Development Plan	Kinarus Therapeutics Holding AG
17-Jan-2023	Relief Therapeutics Announces IRB Approval of Investigator-Initiated Trial Evaluating RLF-TD011 as an Adjunctive Treatment for Cutaneous T-Cell Lymphom	Relief Therapeutics Holding SA
16-Jan-2023	Defence Therapeutics Inc.: DEFENCE ACCUMTM ACCEPTED US PATENT TO BOLSTER ITS VACCINE PLATFORM TECHNOLOGY IP	Defence Therapeutics Inc.
16-Jan-2023	BRAIN Biotech AG reports record figures in fiscal year 2021/22 − despite challenging geopolitical environment	BRAIN Biotech AG
16-Jan-2023	Xlife Sciences portfolio company launches project to research a potential therapy for amyotrophic lateral sclerosis (ALS)	Xlife Sciences AG
13-Jan-2023	Moderna joins the Association of the British Pharmaceutical Industry	Association of the British Pharmaceutical Industry (ABPI)
13-Jan-2023	Tezspire approved for self-administration in the EU in a new pre-filled pen	AstraZeneca
12-Jan-2023	Sanofi Ventures announces multi-year capital commitment from Sanofi, increasing evergreen fund to $750M	Sanofi Ventures
12-Jan-2023	Avillion announces US approval of AstraZeneca’s Airsupra (PT027) as new rescue treatment for asthma	Avillion
12-Jan-2023	New Phesi global analysis sees breast cancer retain position as most studied disease area in 2022	Phesi
12-Jan-2023	First and only rescue medication approved in the US for as-needed use to reduce risk of asthma exacerbations	AstraZeneca
12-Jan-2023	Biophytis to take appropriate measures after receiving Nasdaq deficiency notice	Biophytis
11-Jan-2023	ABL SA group acquires Berlin based Medtech company Humedics	ABL SA
11-Jan-2023	Valo Therapeutics selects Exothera to develop large-scale oncolytic adenovirus manufacturing	Valo Therapeutics